Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Baikal Skullcap (Scutellaria baicalensis) has been used in traditional Chinese medicine for centuries, but its use to support chemotherapy and reduce chemotherapy-induced side effects is primarily justified by emerging scientific evidence, although this evidence is still limited and preliminary. Several preclinical studies have demonstrated that certain flavonoids found in Baikal Skullcap, such as baicalin and baicalein, exhibit anti-inflammatory, antioxidant, and cytoprotective properties. These compounds have shown potential in reducing oxidative stress and inflammation, which are common side effects associated with chemotherapy.

Some animal studies and in vitro experiments suggest that extracts from Scutellaria baicalensis may protect normal cells from chemotherapy-induced toxicity without diminishing the anti-tumor effects of chemotherapeutic agents. For example, baicalin has been shown to attenuate cisplatin-induced nephrotoxicity in animal models and reduce gastrointestinal damage from certain chemotherapies. However, high-quality human clinical trials are sparse. The few available human studies are small, lack rigorous controls, or focus on related applications, such as general inflammation or liver protection, rather than direct reduction of chemotherapy side effects.

Overall, while there is some promising preclinical evidence and a basis for further investigation, the use of Baikal Skullcap to reduce chemotherapy side effects is not yet well validated in humans. Therefore, its use is rated low (2/5) for scientific support in this context, and patients should consult healthcare professionals before using it alongside chemotherapy.

More about Baikal Skullcap
More about Chemotherapy (reducing side effects)

Other ingredients used for Chemotherapy (reducing side effects)

Other health conditions supported by Baikal Skullcap

Products containing Baikal Skullcap